Composition and method for radiation synovectomy of arthritic joints
    1.
    发明授权
    Composition and method for radiation synovectomy of arthritic joints 失效
    关节炎关节放射性滑膜切除术的组成和方法

    公开(公告)号:US4889707A

    公开(公告)日:1989-12-26

    申请号:US150154

    申请日:1988-01-29

    IPC分类号: A61K9/16 A61K51/12

    摘要: Radioactive microspheres for radiation synovectomy of arithmetic joints in a mammal comprise a biodegradable glass material and a beta radiation emitting radioisotope chemically dissolved in and distributed substantially uniformly throughout the glass material. The biodegradable glass material may be lithium silicate, lithium aluminosilicate, lithium aluminoborate, lithium germanate, lithium aluminogermanate, potassium silicate, potassium aluminosilicate, potassium, aluminoborate, potassium germanate or potassium aluminogermanate and the beta radiation emitting radioisotope may be samarium-153, holmium-166, erbium-169, dysprosium-165, rhenium-186, rhenium-188 or yttrium-90. Methods for preparing such microspheres and for carrying out radiation synovectomy of arthritic joints utilizing such microspheres are also disclosed.

    摘要翻译: 放射性微球用于哺乳动物运算关节的放射性滑膜切除术包括可生物降解的玻璃材料和化学溶解并基本上均匀分布在玻璃材料中的β辐射放射性同位素。 可生物降解的玻璃材料可以是硅酸锂,铝硅酸锂,铝硼酸锂,锗酸锂,铝锗酸钾,硅酸钾,硅铝酸钾,钾,铝硼酸钾,锗酸钾或铝氟酸钾,β辐射放射性同位素可以是钐-153, 166,铒-169,镝-165,铼-188,铼-188或钇-90。 还公开了使用这种微球制备这种微球并进行关节炎关节的放射性滑膜切除术的方法。

    Radiolabeled protein composition and method for radiation synovectomy
    2.
    发明授权
    Radiolabeled protein composition and method for radiation synovectomy 失效
    放射性标记的放射性滑膜切除术的蛋白质组成和方法

    公开(公告)号:US5403573A

    公开(公告)日:1995-04-04

    申请号:US872899

    申请日:1992-04-23

    IPC分类号: A61K51/08 A61K51/12 A61K43/00

    摘要: A radiolabeled protein composition adapted for radiation therapy which comprises a radioisotope and a protein material containing about 6 or more percent amino acids which have a sulfhydryl-containing side chain. A method for carrying out radiation synovectomy of arthritic joints. Rhenium radiolabeled protein microspheres are administered which contain cysteine and other amino acids. A method for radiolabeling a protein composition whereby the composition is treated with a reducing agent capable of reducing disulfides to sulfhydryls prior to radiolabeling.

    摘要翻译: 适于辐射治疗的放射性标记的蛋白质组合物,其包含放射性同位素和含有约6个或更多个具有含巯基侧链的氨基酸的蛋白质材料。 一种进行关节炎关节放射性滑膜切除术的方法。 施用含有半胱氨酸和其他氨基酸的铼放射性标记的蛋白质微球。 一种用于放射性标记蛋白质组合物的方法,其中组合物用能够在放射性标记之前将二硫键还原成巯基的还原剂进行处理。

    Composition and method for radiation synovectomy of arthritic joints
    4.
    发明授权
    Composition and method for radiation synovectomy of arthritic joints 失效
    关节炎关节放射性滑膜切除术的组成和方法

    公开(公告)号:US5011797A

    公开(公告)日:1991-04-30

    申请号:US408115

    申请日:1989-09-15

    IPC分类号: A61K9/16 A61K51/12

    摘要: Radioactive microspheres for radiation synovectomy of arthritic joints in a mammal comprises a biodegradable glass material and a beta radiation emitting radioisotope chemically dissolved in and distributed substantially uniformly throughout the glass material. The biodegradable glass material may be lithium silicate, lithium aluminosilicate, lithium aluminoborate, lithium germanate, lithium aluminogermanate, potassium silicate, potassium aluminosilicate, potassium aluminoborate, potassium germanate or potassium aluminogermanate and the beta radiation emitting radioisotope may be samarium-153, holmium-166, erbium-169, dysprosium-165, rhenium-186, rhenium-188 or yttrium-90. Method for preparing such microspheres and for carrying out radiation synovectomy of arthritic joints utilizing such microspheres are also disclosed.

    摘要翻译: 用于哺乳动物关节炎关节放射性滑膜切除术的放射性微球包括可生物降解的玻璃材料和化学溶解并基本上均匀分布在玻璃材料中的β辐射放射性同位素。 可生物降解的玻璃材料可以是硅酸锂,铝硅酸锂,铝硼酸锂,锗酸锂,铝硅酸铝,硅酸钾,硅铝酸钾,铝硼酸钾,锗酸钾或氟铝酸钾,β辐射放射性同位素可以是钐-153,钬-166 ,铒-169,镝-165,铼-188,铼-188或钇-90。 还公开了使用这种微球制备这种微球体并进行关节炎关节的放射性滑膜切除术的方法。

    Composition and method for radiation synovectomy of arthritic joints
    6.
    发明授权
    Composition and method for radiation synovectomy of arthritic joints 失效
    关节炎关节放射性滑膜切除术的组成和方法

    公开(公告)号:US5039326A

    公开(公告)日:1991-08-13

    申请号:US408087

    申请日:1989-09-15

    IPC分类号: A61K9/16 A61K51/12

    摘要: A method for preparing nonradioactive microspheres adapted for radiation synovectomy of arthritic joints in a mammal involves forming the microspheres by doping a biodegradable glass material which may be lithium or potassium silicate, lithium or potassium aluminosilicate, lithium or potassium aluminoborate, lithium or potassium germanate or lithium or potassium aluminogermanate with an isotope which may be samarium, holmium, erbium, dysprosium, rhemium or yttrium so that the isotope is chemcially dissolved in and distributed uniformly throughout the glass material. The doped glass material is then treated with an acid wash to produce a thin layer on the surface thereof and heat treated to improve the chemical durability of the glass material by rendering the solubility of the layer lower than that of the underlying glass material.

    摘要翻译: 适用于哺乳动物关节炎关节放射性滑膜切除术的非放射性微球的方法包括通过掺入可生物降解的玻璃材料来形成微球,所述可生物降解的玻璃材料可以是硅酸锂或硅酸钾,铝硅酸锂或钾,铝硼酸锂或钾,锗酸锂或钾, 或具有可能是钐,钬,铒,镝,铼或钇的同位素的铝锗酸钾,使得同位素化学溶解并均匀分布在整个玻璃材料中。 然后将掺杂的玻璃材料用酸洗处理以在其表面上产生薄层并进行热处理,以通过使层的溶解度低于下层玻璃材料的溶解度来改善玻璃材料的化学耐久性。

    Controlling vessel growth and directionality in mammals and implantable material
    9.
    发明授权
    Controlling vessel growth and directionality in mammals and implantable material 有权
    控制哺乳动物和可植入材料中的血管生长和方向性

    公开(公告)号:US08337875B2

    公开(公告)日:2012-12-25

    申请号:US12683211

    申请日:2010-01-06

    IPC分类号: A61F2/00

    摘要: A method for directing vessel growth toward a blood-deficient site in a mammal comprising implanting into the mammal an assembly of at glass fibers to form a vascular bridge with a first end of the vascular bridge in contact with the blood-deficient site and a second end of the vascular bridge remote from the blood-deficient site. Over time the bridge biodegrades and promotes vascularity in the direction of the bridge.

    摘要翻译: 一种用于将血管生长导向哺乳动物的血液缺乏部位的方法,包括向玻璃纤维植入哺乳动物组件以形成与血液缺陷部位接触的血管桥的第一端的血管桥,第二 远离血液缺乏部位的血管桥端。 随着时间的推移,桥梁在桥梁的方向上生物降解和促进血管分布。